omegatherapeutics.com - Kapitalisasi Buku OMGA

Logo perusahaan publik Omega Therapeutics, Inc. (OMGA)

This chart shows that the current share price of Omega Therapeutics (OMGA) stands at 0.01. The business is currently characterized exclusively by cash burn, as the trial stage for new drugs is in its early phases and there are no stable revenue streams. Omega Therapeutics (OMGA) is pursuing global growth by scaling its digital developments. The project's objective is the systemic therapy of metabolic and oncological pathologies through the precise regulation of gene activity.

omegatherapeutics.com (OMGA) - Nilai Buku Perusahaan saka 04.07.2022 nganti 08.03.2025
Barang unggulan Omega Therapeutics

The development of a diversified portfolio of epigenetic drugs across various therapeutic areas reduces risks for Omega Therapeutics (OMGA), which is reflected in the accumulation of net assets. By analyzing the dynamics of total balance sheet capital, an investor can see the real value of equity minus liabilities, allowing for a comparison with the market price to determine the fundamental discount or overvaluation of the issuer's shares.

Pesaing wigati

TEM - Nilai Buku Bisnis|QGEN: Kapitalisasi Buku|ionispharma.com (IONS) - Kapitalisasi Buku|Kapitalisasi Buku Repligen (RGEN)|Kapitalisasi Akuntansi RNA|Nilai Buku Perusahaan CRISPR Therapeutics Corp CRSP|Kapitalisasi Akuntansi GeneDx Corp (WGS)|Kapitalisasi Buku RARE (Ultragenyx Pharmaceutical)|beamtx.com - Kapitalisasi Buku|SRPT (Sarepta) - Nilai Buku Perusahaan|TWST: Ekuitas Perusahaan|TXG (10x Genomics Corp) - Nilai Buku Perusahaan|Intellia Corp (NTLA) - Aset Bersih Perusahaan|Kapitalisasi Buku STOK (Stoke Therapeutics)|Ekuitas Perusahaan biolifesolutions.com|WVE: Kapitalisasi Buku|Nilai Buku Bisnis Maze Therapeutics, Inc. (MAZE)|Kapitalisasi Buku SION (Sionna Pharma)|PRME - Kapitalisasi Buku|Aset Bersih Perusahaan Taysha Gene Therapies (TSHA)|uniqure.com (QURE) - Nilai Akuntansi Perusahaan|MGTX - Aset Bersih Perusahaan|REGENXBIO Inc (RGNX) - Total Aset Bersih|SLDB - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Ocugen Pharma|Pacific Biosciences - Kapitalisasi Buku|Ekuitas Perusahaan BNTC (benitec.com)|Nilai Buku Perusahaan Design Therapeutics, Inc.|Nilai Akuntansi Perusahaan Rocket Pharma RCKT|4D Molecular Therapeutics Inc - Kapitalisasi Buku|LXEO: Kapitalisasi Buku|Nilai Buku Perusahaan korrobio.com (KRRO)|editasmedicine.com (EDIT) - Nilai Aset Bersih|Kapitalisasi Buku SLN (Silence Therapeutics plc)|Ekuitas Perusahaan ProQR Therapeutics NV (PRQR)|Aset Bersih Perusahaan CDXS|Kapitalisasi Buku Sangamo BioSciences SGMO|Aset Bersih Perusahaan Nautilus Bio (NAUT)|Total Aset Bersih metagenomi.co MGX|Kapitalisasi Buku DTIL (Precision BioSciences)|GBIO - Pambiji Buku Bisnis|BOLD (Boundless Bio, Inc) - Kapitalisasi Buku|XCUR (Exicure) - Aset Bersih Perusahaan|IMNN: Nilai Buku Perusahaan|Pambiji Buku Bisnis PHIO|Mustang Bio, Inc. - Nilai Buku Perusahaan|Ekuitas Perusahaan RNAZ (transcodetherapeutics.com)|Bionano Genomics - Nilai Buku Perusahaan|Aset Bersih Perusahaan Applied DNA Corp APDN|Kapitalisasi Buku BLUE|IPA - Nilai Buku Bisnis|OMIC: Kapitalisasi Buku|Regulus Therapeutics, Inc. (RGLS) - Kapitalisasi Buku|Kapitalisasi Buku Syros (SYRS)|Kapitalisasi Akuntansi TBIO|Nilai Buku Perusahaan TRACON Pharmaceuticals TCON|Kapitalisasi Akuntansi unitybiotechnology.com (UBX)